🔗 Share this article

An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.

Some professionals said the popularity for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the platform has taken down violative content and prohibited related keywords and query recommendations. The organization said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, populated with images of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at home.

After moments of entering one community, a vendor shared contact information, where most transactions occur. The seller provided an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, posts show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially serious health risks”.